MiR26a reverses enzalutamide resistance in a bone-tumor targeted system with an enhanced effect on bone metastatic CRPC

In this study, we iden...

Source: Journal of Nanobiotechnology - April 2, 2024 Category: Nanotechnology Authors: Yuanyuan Wang, Jiyuan Chen, Luyao Gong, Yunxia Wang, Aino Siltari, Yan-Ru Lou, Teemu J. Murtola, Shen Gao and Yuan Gao Tags: Research Source Type: research